Clinical Trials on Mast-Cell Sarcoma in France

Total 4368 results

French Innovative Leukemia Organisation

Completed

Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL

B Cell Chronic Lymphocytic Leukemia

France
European Organisation for Research and Treatment...

Completed

Surgery With or Without Radiation Therapy in Untreated Nonmetastatic Retroperitoneal Sarcoma (STRASS)

Sarcoma

France, Netherlands, United Kingdom, Spain, Canada, Italy, Germany, Belgium, United States, Denmark, Norway, Poland, Sweden
Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
University Hospital, Montpellier

Recruiting

Complication and Lung Function Impairment Prediction Using Perfusion and CT Air Trapping (CLIPPCAIR)

Non-small Cell Lung Cancer

France
Hopital Foch

Unknown

Volatil Organic Compounds in Exhaled Air and Sweat After Thoracic Surgery for Carcinological Resection (Onco-VOC)

Lung Cancer, Non-small Cell

France
University Hospital, Montpellier

Completed

Texture Features and PDL1 in CT-PET 18 FDG

Non Small Cell Lung Cancer

France
University of Paris 5 - Rene Descartes

Completed

Hypermetabolism in the Elderly Lung Cancer Patient (HELP)

Non-small Cell Lung Carcinoma

France
Centre Hospitalier Universitaire de Nice

Unknown

The Method ISET (Insulation by Size of Epithelial Tumor Cells)

Non Small Cell Lung Cancer

France
Nantes University Hospital

Terminated

Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa (Zometa)

Giant Cell Tumors of Bone

France
Princess Maxima Center for Pediatric Oncology
Takeda

Recruiting

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors (Briga-PED)

Anaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid Tumor

France, Netherlands
Central Hospital, Nancy, France

Unknown

ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS (PADAONCODERM)

Melanoma | Skin Cancer | Oncology | Skin Squamous Cell Carcinoma | Advance Directives | Skin Lymphoma | Metastatic Basal Cell Carcinoma

France
University Hospital, Strasbourg, France

Completed

Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour (DENO)

Giant Cell Tumors

France
Sanofi

Terminated

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Non-Small-Cell Lung Carcinoma

France
Sanofi

Completed

Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (GON)

Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Prevalence of Mood and Anxiety Disorders in Adult Patients With Pulmonary Langerhans Cell Histiocytosis (PsyHistio)

Pulmonary Langerhans Cell Histiocytosis

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR)

Non-small Cell Lung Cancer

France
Hopital Foch

Terminated

Volatile Organic Compounds in Exhaled Air and Sweat of Patients Treated by Immunotherapy for Lung Cancer: Research on Biomarkers for Early Therapeutic Response (Immuno-VOC)

Lung Cancer, Non-small Cell

France
Gustave Roussy, Cancer Campus, Grand Paris

Completed

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes (CSET 1437)

Non Small Cell Lung Cancer

France
Centre Oscar Lambret

Completed

Study of the Expression of Met Receptor Fragments in Non Small Cell Lung Cancers (MetLung)

Non Small Cell Lung Cancer

France
University Hospital, Rouen

Completed

Evaluation of Preoperative Endobronchial Ultrasound (EBUS) in Non Small Cell Lung Cancer (NSCLC) (EVIEPEB)

Non Small Cell Lung Cancer

France
Centre Leon Berard
French Immunotherapy Intergroup; SCAPP (Sub-Cutaneous Administration Proleukin...

Completed

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Metastatic Renal Cell Carcinoma

France
Centre Leon Berard

Terminated

Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay (THEODORA)

Sarcoma | Rectal Carcinoma | Esophagus Cancer

France
University Hospital, Tours
Hôpital Cochin

Recruiting

Evaluation of Prime-boost Anti-pneumococcal Vaccination in Patients With Diffuse Large B Cell Lymphoma Treated With Rituximab (EVAPOR)

Lymphoma, Large B-Cell, Diffuse | Pneumococcal Infections

France
Centre Henri Becquerel

Recruiting

Dynamics of 18-FDG Uptake in Stage III/IV Non Small Cell Lung Cancer During First Line Pembrolizumab Treatment (iTEP1)

Non Small Cell Lung Cancer

France
Centre Hospitalier Universitaire de Nīmes
MEDEXPRIM; GRATICULE

Completed

Predicting Response to PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging and Clinical Data (Onc AI)

Non-small Cell Lung Cancer (NSCLC)

France
Assistance Publique - Hôpitaux de Paris
Pfizer

Completed

Clinical Trial to Assess the Importance of Nephrectomy (CARMENA)

Metastatic Renal Cell Carcinoma

France
Centre Henri Becquerel
Intergroupe Francophone de Cancerologie Thoracique

Unknown

Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC (RTEP7)

Non-small Cell Lung Cancer

France
University Hospital, Bordeaux

Completed

Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers (PULMOTEP)

Lung Cancer | Non-small-cell Lung Carcinoma

France
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb

Terminated

Tumor Mutational Burden in Lung Cancer Patients (MUBULUC)

Non Small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IV | Non Small Cell Lung Cancer Stage III | Non-Small Cell Carcinoma of Lung

France
Centre Henri Becquerel

Recruiting

Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL) (CAMIL)

Primary Mediastinal Large B-cell Lymphoma

France
University Hospital, Lille

Withdrawn

IL-33, Endocan and Endothelial Cells (IL-33)

Endothelial Cell

France
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling (VaPosVent)

Resectable Lung Non-Small Cell Carcinoma

France
Assistance Publique Hopitaux De Marseille

Terminated

Phase I Multicenter Trial Combining Nivolumab, Ipilimumab and Hypo-fractionated Radiotherapy for Pretreated Advanced Stage Non-small Cell Lung Cancer Patients

Non-small Cell Lung Cancer

France
Poitiers University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Completed

Prognostic PET/CT Model in Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

France
Assistance Publique - Hôpitaux de Paris
Pfizer; National Cancer Institute, France

Terminated

Biological, Pathological and Imagery Markers in the First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma (PREINSUT)

Metastatic Renal Cell Carcinoma

France
University Hospital, Bordeaux

Completed

Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma (ChemoRenCan)

Kidney Neoplasms | Kidney Diseases | Carcinoma | Carcinoma Renal Cell | Chemokines

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck (ELAN-ONCOVAL)

Inoperable Squamous Cell Cancer of the Head and Neck

France
Central Hospital, Nancy, France

Recruiting

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation (REAL-GREFFE)

Allogeneic Hematopoietic Stem Cell Transplantation

France
Central Hospital, Nancy, France

Completed

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation (AMS-haplo)

Stem Cell Transplantation | Haplo-identical

France
French Innovative Leukemia Organisation
University Hospital, Lille

Recruiting

Observatory of Prolymphocytic Leukemia T (T-PLL)

Prolymphocytic Leukemia | T-cell Leukemia

France
University Hospital, Toulouse

Recruiting

A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse (MIRACLE)

Non-small Cell Lung Cancer Stage IIIA

France
Immutep S.A.S.
Umanis

Completed

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Stage IV Renal Cell Carcinoma

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (ELDERGRAF)

Stem Cell Transplant

France
Centre Hospitalier Régional Metz-Thionville

Completed

Quantification of Factors Influencing Endothelial Damage During Phacoemulsification (PREDICSPILOT)

Cataract | Endothelial Cell Loss, Corneal | Phacoemulsification

France
Janssen-Cilag Ltd.

Completed

A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice (FIRE)

Lymphoma, Mantle-Cell | Leukemia, Lymphocytic, Chronic, B-Cell

France
Hospices Civils de Lyon

Completed

EBV-associated Diffuse Large B Cell Lymphoma

To Characterize and Compare Clinical, Pathological and Molecular Features

France
Centre Hospitalier Universitaire Dijon

Not yet recruiting

Pilot Study of the Contribution of Fractional Exhaled Nitric Oxide as a Prognostic Marker of Response to Anti-PD-L1 Immunotherapy in Non-small Cell Lung Cancer (FENOTYPE)

Metastatic Non-small Cell Lung Cancer

France
University Hospital, Brest

Recruiting

Retrospective Observational Study on Prediction of Response to PD-1 Immunotherapy in Patients With NSCLC (PREDICTION)

Advanced Non Small Cell Lung Cancer

France
Assistance Publique Hopitaux De Marseille

Active, not recruiting

Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance (PIONeeR-BioMarkers (BM) Profiling) (PIONeeR)

Non-small Cell Lung Cancer Patients

France
Hospices Civils de Lyon

Completed

IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer

Stage IV Non-small Cell Lung Cancer

France

Clinical Trials on Mast-Cell Sarcoma in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations